VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc.

Rhea-AI Summary

VTAK (NYSE American: VTAK) acquired a 19.98% strategic minority stake in Fly Flyte, Inc. on Feb. 17, 2026, gaining immediate exposure to a revenue-generating, FAA Part 135 certified regional operator using AI-enabled operations and a fleet of Cirrus Vision Jets.

The investment preserves Flyte control, targets scalable fleet expansion, and provides optionality for increased ownership or future monetization while aligning VTAK with short-haul regional mobility ahead of potential eVTOL commercialization.

Positive

• 19.98% equity stake acquired in Flyte on Feb 17, 2026
• Immediate revenue exposure to an operating, FAA Part 135 certified air carrier
• AI-enabled operations across routing, pricing, dispatch and utilization

Negative

• Minority position limits control and immediate strategic influence
• Transaction subject to customary closing conditions, including shareholder approval

News Market Reaction – VTAK

+11.89%

6 alerts

+11.89% News Effect

+13.5% Peak Tracked

-3.5% Trough Tracked

+$284K Valuation Impact

$3M Market Cap

0.8x Rel. Volume

On the day this news was published, VTAK gained 11.89%, reflecting a significant positive market reaction. Argus tracked a peak move of +13.5% during that session. Argus tracked a trough of -3.5% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $284K to the company's valuation, bringing the market cap to $3M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Ownership stake: 19.98% equity FAA certificate number: 1POA402M Operating regulation: FAA 14 CFR Part 135

3 metrics

Ownership stake 19.98% equity VTAK strategic minority investment in Fly Flyte, Inc.

FAA certificate number 1POA402M Ponderosa Air FAA Air Carrier Certificate No. 1POA402M

Operating regulation FAA 14 CFR Part 135 Flyte flight operations under FAA 14 CFR Part 135

Market Reality Check

Price: $1.61 Vol: Volume 1,152,342 vs 20-da...

high vol

$1.61 Last Close

Volume Volume 1,152,342 vs 20-day average 159,079 (relative volume 7.24x). high

Technical Price 1.43 trading below 200-day MA at 3.17, far under 52-week high 15.6805.

Peers on Argus

VTAK up 12.6% with elevated volume, while 3 momentum-screened medical device pee...

3 Up

VTAK up 12.6% with elevated volume, while 3 momentum-screened medical device peers (e.g., BBLG, BJDX, BMRA) also move up (median ~4.1%), indicating broader sector strength alongside company-specific news.

Common Catalyst Sector-wide upside in small-cap medical devices with at least one peer (BJDX) posting clinical progress news the same day.

Historical Context

5 past events · Latest: Feb 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Strategic financing	Positive	-33.2%	Up to $36.5M institutional financing and liability-to-equity conversion to strengthen liquidity.
Feb 05	Product visibility	Positive	-4.8%	LockeT device featured in live cases at major structural heart conference.
Feb 04	Commercial update	Positive	+1.6%	Expanded hospital approvals and record January revenue for LockeT with strong Q1 outlook.
Jan 22	Intl market entry	Positive	+10.4%	First LockeT purchase order in Germany, entering a large electrophysiology devices market.
Jan 20	Global expansion	Positive	-1.9%	New VIVO order in Slovenia, expanding commercial footprint to 15 countries.

Pattern Detected

VTAK often shows mixed or negative short-term reactions to positive operational or financing news, with several recent ‘good news’ events followed by weak or negative price moves.

Recent Company History

Over the last month, VTAK has focused on strengthening its balance sheet and expanding its electrophysiology footprint. A $36.5 million strategic financing and royalty-to-preferred exchange were followed by a sharp -33.16% move. Commercial updates for LockeT and VIVO, including first orders in Germany and expansion to 15 countries, saw both positive and negative single-day reactions. Today’s Fly Flyte stake adds a diversified, AI-enabled aviation asset to this sequence of growth and restructuring steps.

Market Pulse Summary

The stock surged +11.9% in the session following this news. A strong positive reaction aligns with V...

Analysis

The stock surged +11.9% in the session following this news. A strong positive reaction aligns with VTAK’s announcement of a 19.98% stake in Fly Flyte, giving immediate exposure to a revenue-generating, asset-backed aviation platform. The move came after prior financing and product updates that saw mixed price responses, suggesting investors may be rewarding diversification away from pure medical devices. However, the stock remains far below its 52-week high of 15.6805, and prior post-news pullbacks highlight the risk that enthusiasm could fade.

Key Terms

faa-certified, faa 14 cfr part 135, ai-enabled, autonomous landing, +2 more

6 terms

faa-certified regulatory

"an FAA-certified regional aviation operator utilizing AI-enabled operations"

FAA-certified means a product, aircraft, pilot, repair facility or process has been reviewed and approved by the U.S. Federal Aviation Administration to meet safety, design and operational standards. For investors, FAA certification is like a safety inspection sticker or a driver's license: it reduces regulatory and operational risk, enables lawful commercial use or sales in the U.S. market, and can be a prerequisite for contracts, insurance and wider market access.

faa 14 cfr part 135 regulatory

"operating under FAA 14 CFR Part 135, deploying Vision Jets"

FAA 14 CFR Part 135 is the set of U.S. aviation rules that govern smaller commercial flight operations such as charters, air taxis, and some commuter services. It lays out safety, maintenance, pilot training, and operational limits—think of it as a business license with strict road rules for companies that run on-demand or small-schedule flights. For investors, Part 135 status affects a carrier’s cost structure, legal exposure, growth limits and reliability, which in turn influence revenue and risk.

ai-enabled technical

"an FAA-certified regional aviation operator utilizing AI-enabled operations"

AI-enabled describes a product, service, or process that uses artificial intelligence—software that learns from data and makes decisions or predictions—as a core feature rather than a minor add-on. For investors it matters because AI-enabled offerings can boost productivity, lower costs or unlock new revenue streams; like adding a smart autopilot to a routine task, they can change a company's growth potential and competitive edge while also bringing higher upfront investment needs and distinct regulatory or ethical risks.

autonomous landing technical

"Safe Return™ autonomous landing technology - advanced safety features"

Autonomous landing is the capability of an aircraft, drone or spacecraft to touch down without real-time human control, using onboard sensors, software and guidance systems to steer, slow and position the vehicle safely. For investors, it matters because reliable autonomous landing can lower operating costs, expand use cases (like remote deliveries or reusable rockets), and reduce regulatory and insurance hurdles—similar to how a self-parking car reduces need for driver skill and lowers accident risk.

evtol technical

"ahead of anticipated future industry-wide eVTOL commercialization"

eVTOL stands for "electric vertical takeoff and landing" aircraft, which are small, electric-powered vehicles capable of taking off and landing vertically like a helicopter. They are designed to provide quick, on-demand transportation within cities or between locations, potentially transforming urban mobility. For investors, eVTOLs represent a growing segment of innovative transportation technology with potential for significant market impact and future growth.

form 8-k regulatory

"refer to the Company’s Current Report on Form 8-K filed February 6, 2026"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

AI-generated analysis. Not financial advice.

Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization

Strategic Investment Expands Capital Allocation into High-Growth Infrastructure with Scalable Fleet Expansion and Long-Term Equity Upside

Fort Mill, S.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced a strategic minority investment in Fly Flyte, Inc. (“Flyte”), an FAA-certified regional aviation operator utilizing AI-enabled operations and a growing fleet of Cirrus Vision Jets.

Flyte conducts its flight operations through its wholly owned subsidiary, Ponderosa Air, LLC (FAA Air Carrier Certificate No. 1POA402M), operating under FAA 14 CFR Part 135, deploying Vision Jets across high-frequency short-haul regional routes where commercial airline capacity remains constrained. The company is generating revenue today with its fleet of Vision Jets, equipped with a proprietary whole-aircraft parachute system and Safe Return™ autonomous landing technology - advanced safety features that position the aircraft among the safest in the world.

The transaction provides VTAK immediate exposure to an operating aviation business supported by tangible assets, scalable fleet expansion capability and technology-driven operating optimization.

Transaction Overview

• VTAK acquires 19.98% equity ownership in Flyte, aligning long-term strategic upside
• Immediate exposure to one of the fastest-growing segments of private aviation
• Asset-backed, scalable fleet expansion model
• Preserves Flyte’s operating continuity and strategic control
• Creates optionality for increased ownership or future monetization

“The aviation sector is seeing accelerating investment in AI-enabled technologies designed to enhance mobility and drive operating efficiencies,” said David Jenkins, CEO and Chairman of VTAK. “Flyte combines certified operations, scalable fleet economics and technology-enabled optimization in a model built for disciplined growth and long-term value creation.”

Why Flyte

• Revenue-generating business operating today - not pre-revenue
• FAA Part 135 certified operator currently servicing multiple regions
• AI-enabled optimization across routing, pricing, dispatch and utilization
• Capital-efficient, asset-backed growth model
• Fleet of Vision Jets recognized for advanced integrated safety systems

Flyte expects disciplined expansion across select regional markets, targeting scalable revenue growth while maintaining capital efficiency.

Strategic Positioning Ahead of Future eVTOL Deployment

• Operates in the same short-haul regional markets targeted by eVTOL developers
• Generates operating data, route density and customer insights today
• Utilizes certified aircraft, trained crews and established regulatory infrastructure
• Provides current revenue exposure while preserving long-term strategic optionality

Significant capital has flowed into advanced air mobility and electric vertical takeoff and landing (eVTOL) companies, several of which trade at multi-billion-dollar public market valuations. While these companies represent long-term aviation innovation, certification and commercial deployment timelines could take years before commercially available.

Flyte operates today in the same corridors targeted for future electric aircraft integration. By leveraging certified aircraft and established infrastructure, Flyte generates active revenue, customer engagement and route density in markets attracting substantial long-term capital investment.

This positioning enables participation in the evolution of regional air mobility without reliance on future certification milestones, pairing current revenue generation with long-term structural upside.

Strategic Impact for VTAK

• Diversifies capital allocation into high-growth transportation infrastructure
• Adds exposure to AI-enabled aviation operations supported by tangible assets
• Creates potential embedded equity upside as Flyte scales
• Maintains disciplined minority position with strategic flexibility to increase ownership

“This investment provides VTAK shareholders exposure to an infrastructure-backed, revenue-generating aviation business positioned within one of the fastest-evolving segments of mobility,” Jenkins added. “Flyte’s certified operations and scalable fleet model allow us to participate in structural industry evolution while maintaining disciplined capital allocation.”

The investment reflects VTAK’s broader strategy of selectively deploying capital into operating businesses with scalable infrastructure, defensible technology and clear paths to long-term value creation.

Flyte Perspective

“Flyte is operating today with certified aircraft, established routes and scalable infrastructure,” said Marc Sellouk, CEO and Founder of Flyte. “Our model is rooted in disciplined execution, capital efficiency and measured growth, positioning us for the long-term evolution of regional air mobility.”

“Demand for premium short-haul connectivity is accelerating, and Flyte is purpose-built for this moment — combining real operations, real infrastructure and a scalable fleet strategy focused on execution and long-term value creation,” Sellouk added.

Additional Information

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Please refer to the Company’s Current Report on Form 8-K filed February 6, 2026 for additional details regarding the transaction, which is subject to customary closing conditions, including shareholder approval.

About Flyte

Flyte is a pioneering private aviation company transforming regional air travel through accessibility, convenience, and technology-driven innovation. Leveraging a seamless booking platform and an on-demand operating model, Flyte delivers a more efficient and scalable alternative to traditional private jet charter.
For more information, visit https://Flyte.travel.

About Catheter Precision

Catheter Precision is an innovative U.S.-based medical device company developing advanced solutions to improve the treatment of cardiac arrhythmias. The company focuses on bringing new technologies to market through collaboration with physicians and continuous product innovation.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to risks and uncertainties described in the Company’s filings with the SEC, available at www.sec.gov. The Company undertakes no obligation to update forward-looking statements except as required by law.

CONTACTS:

Investor Relations
973-691-2000
IR@catheterprecision.com

FAQ

What stake did VTAK acquire in Flyte and when was the deal announced?

VTAK acquired a 19.98% equity stake in Flyte, announced on Feb. 17, 2026. According to VTAK, the minority investment provides immediate exposure to Flyte’s operating aviation business and tangible asset-backed fleet.

How does the Flyte investment give VTAK revenue exposure today (VTAK)?

The investment gives VTAK exposure to a revenue-generating Part 135 operator currently flying Vision Jets. According to Flyte, operations are active across multiple regions, producing current revenue and customer engagement on short-haul routes.

What operational advantages does Flyte claim with its fleet and technology for VTAK investors?

Flyte operates certified Vision Jets with integrated safety systems and Safe Return™ autonomous landing tech. According to Flyte, AI-driven routing and pricing optimize utilization and support capital-efficient fleet scaling across regional corridors.

Does the VTAK stake give the company control of Flyte or options to increase ownership?

The 19.98% stake is a minority position that preserves Flyte’s strategic control. According to VTAK, the structure creates optionality for increased ownership or future monetization but does not transfer control today.

What regulatory and closing conditions affect VTAK’s Flyte investment (VTAK)?

The transaction remains subject to customary closing conditions, including shareholder approval and other customary items. According to VTAK, completion depends on those conditions and the Form 8-K filed Feb. 6, 2026 provides additional details.